Citation Impact
Citing Papers
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
2013 StandoutNobel
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
2010 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
2015
Monocyte recruitment during infection and inflammation
2011 Standout
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
2019
The dual role of neutrophils in cancer
2021
Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma
2013
Profile of Tumor Antigen-Specific CD8 T Cells in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma
2009
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Hepatocellular carcinoma
2021 Standout
CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice
2010
Epigenetics in cancer
2009 Standout
DNA hypomethylation and human diseases
2006
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses
2009 StandoutNobel
DNA methylation landscapes: provocative insights from epigenomics
2008 Standout
Tumour-associated neutrophils in patients with cancer
2019
Neutrophil diversity and plasticity in tumour progression and therapy
2020
Identification and analysis of tumour-associated antigens in hepatocellular carcinoma
2005
Granulocyte Colony–Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients With Acute-on-Chronic Liver Failure
2011
Global burden of liver disease: 2023 update
2023 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
2006
During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes
2022
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial
2017
Regulatory T cells in tumor immunity
2010 StandoutNobel
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
Epigenetic modifications and human disease
2010 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Gut microbiota in human metabolic health and disease
2020 Standout
Caffeine Inhibits the Activation of Hepatic Stellate Cells Induced by Acetaldehyde via Adenosine A2A Receptor Mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK Signal Pathway
2014
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function
2018
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
The efficacy and safety of entecavir in patients with chronic hepatitis B- associated liver failure: a meta-analysis
2015
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.
2010 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro
2010
Overcoming regulatory T‐cell suppression by a lyophilized preparation of Streptococcus pyogenes
2013 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of Ran Fei being referenced
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
2015
Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2
2009
Hematopoietic stem cells mobilized by granulocyte colony-stimulating factor partly contribute to liver graft regeneration after partial orthotopic liver transplantation
2006
Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines
2005
Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China
2017
[Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma].
2003
Effect of interferon-gamma on hepatic stellate cells stimulated by acetaldehyde.
2008
Performance Comparison of the Versant HCV Genotype 2.0 Assay (LiPA) and the Abbott Realtime HCV Genotype II Assay for Detecting Hepatitis C Virus Genotype 6
2014
Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis.
2012
The Spontaneous CD8+ T-Cell Response to HLA-A2-Restricted NY-ESO-1b Peptide in Hepatocellular Carcinoma Patients
2004